• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Copley Scientific banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

From inhalable vaccines to inhalable caffeine (updated March 7, 2012)

Update 3/7/2012: The FDA issues a warning letter on inhalable caffeine.

Update 2/19/2012: The FDA says it will review the safety and legality of AeroShot inhaled caffeine.

In 2008, Harvard professor David Edwards gave a talk to the AAPS Inhalation and Nasal Technology Focus Group (INTFG) titled “Inhaled Drugs and Vaccines for Infectious Diseases in Low-Income Settings,” a review of work done by his charitable organization Medicine in Need. Four years later, Edwards is speaking up to defend his latest product against charges by a US senator that the inhaled dry powder formulation of caffeine, is “nothing more than a club drug” that “could be a dangerous health hazard,” allowing partiers to “drink until they drop.”

In December 2011, Senator Chuck Schumer of New York issued a press release along with a letter to the FDA requesting an investigation into the safety and legality of the AeroShot dry powder inhaler.

AeroShot inhaler

The AeroShot caffeine inhaler

Schumer expressed particular concern about the marketing of the product to children and teens, noting that the Edwards’ company, Breathable Foods, claimed that the product was healthy and safe for children over 12 — a claim that the company has apparently revised since the AeroShot website now advises that the inhaler is not recommended for anyone under age 18.

According to website, the AeroShot formulation includes approximately 100 mg of caffeine, B vitamins, sweeteners, natural flavor, citric acid, and sodium bicarbonate, all of which are considered generally recognized as safe (GRAS) by the FDA. The makers claim that each puff provides about 15-25 mg caffeine “as an estimate” and that “Caffeine has been proven to offer a variety of potential benefits for health to individuals when consumed in moderation, from providing energy to enhancing attention and focus.” One of the promotional slogans on the site is “Puff in. Be on.”

The AeroShot website also categorically denies the possibility of any particles reaching the respiratory tract: “Our powders are of a median size much larger than 10 microns, and therefore, as confirmed by independent laboratory studies, they cannot enter the lung.”

In an Associated Press video, Edwards compares the inhaler to drinking a cup of coffee, “or maybe a Red Bull,” and says that the advantage of the inhaler is “that it’s the act of breathing.” He says, “The fact that you can avoid overdosing; the fact that you can deliver caffeine with no calories; the fact that you have no secondary or tertiary molecules like taurine and so forth that amplify the caffeine effect are all reasons to consider AeroShot as an eminently safe product.”

Watch the AP video below:

Share

published on February 9, 2012

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Aptar Pharma banner
    © 2025 OINDPnews